Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.05p
   
  • Change Today:
      0.19p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 3,515,017
  • Market Cap: £10.24m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £30,514
Lisa Baderoon 583,963 £11,971
Tim Franklin 525,000 £10,762

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,331,109
Luca & Associates AG 22,000,000 £451,000
Invesco Ltd 17,872,341 £366,383
Aviva Investors Global 11,285,180 £231,346
Alora Pharmaceuticals LLC 10,909,091 £223,636
M&G Investments 7,600,000 £155,800
Prudential plc 7,600,000 £155,800
Capital Income Builder 4,870,367 £99,842
Dr R Zimmer 4,551,553 £93,307
Odey Asset Management 3,433,319 £70,383
Rhone Trustees (Switzerland) SA 3,386,000 £69,413
Pictet Overseas Trust Corporation Limited 3,287,500 £67,394

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.05p
Change Today 0.19p
% Change 9.92 %
52 Week High 5.90
52 Week Low 1.09
Volume 3,515,017
Shares Issued 499.72m
Market Cap £10.24m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.44% below the market average29.44% below the market average29.44% below the market average29.44% below the market average29.44% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
50.8% below the market average50.8% below the market average50.8% below the market average50.8% below the market average50.8% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 17-Jul-2025

Time Volume / Share Price
16:40 1 @ 2.05p
16:40 1 @ 2.05p
16:29 57,600 @ 2.25p
16:27 90,088 @ 2.25p
16:24 110,935 @ 2.25p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page